BioCentury
ARTICLE | Company News

Vertex, Trek Therapeutics deal

August 1, 2016 7:00 AM UTC

Vertex granted Trek exclusive, worldwide rights to develop and commercialize lomibuvir ( VX-222) and merimepodib ( VX-497) to treat infectious disease. Vertex is eligible for undisclosed milestones an...